<div id="readability-page-1"><p>Thurston Springer Miller Herd &amp; Titak Inc. lowered its stake in shares of  Xylem Inc. (NYSE:XYL - Free Report) by 91.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor  owned 1,691 shares of the industrial products company's stock after selling 18,715 shares during the quarter. Thurston Springer Miller Herd &amp; Titak Inc.'s holdings in Xylem were worth $249,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p><ul><li>3 Sustainable Stocks Benefiting From the AI Energy Surge</li></ul><p>Several other institutional investors and hedge funds also recently added to or reduced their stakes in XYL. Renaissance Investment Group LLC raised its holdings in shares of  Xylem by 0.4% in the third quarter. Renaissance Investment Group LLC now owns 81,762 shares of the industrial products company's stock worth $12,060,000 after buying an additional 332 shares during the last quarter.  Canandaigua National Bank &amp; Trust Co. purchased a new stake in  Xylem in the third quarter valued at approximately $208,000.  Assenagon Asset Management S.A. increased its holdings in  Xylem by 306.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 414,119 shares of the industrial products company's stock worth $61,083,000 after buying an additional 312,227 shares during the period.  Aaron Wealth Advisors LLC raised its position in  Xylem by 147.9% during the 3rd quarter. Aaron Wealth Advisors LLC now owns 5,822 shares of the industrial products company's stock worth $859,000 after buying an additional 3,473 shares during the last quarter.  Finally, GAMMA Investing LLC raised its position in  Xylem by 14.9% during the 3rd quarter. GAMMA Investing LLC now owns 4,808 shares of the industrial products company's stock worth $709,000 after buying an additional 625 shares during the last quarter. Hedge funds and other institutional investors own  87.96% of the company's stock. </p><h2>Analyst Ratings Changes</h2><p>XYL has been the topic of a number of research reports. Argus  set a $170.00 price objective on shares of Xylem in a research note on Wednesday, October 29th. Stifel Nicolaus upped their price target on shares of Xylem from $175.00 to $178.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, October 29th. Robert W. Baird  set a $178.00 price objective on Xylem in a research note on Wednesday, October 29th. Zacks Research downgraded Xylem from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, November 18th. Finally, TD Cowen raised their target price on Xylem from $130.00 to $135.00 and gave the stock a &#34;hold&#34; rating in a report on Friday, December 5th. Eight research analysts have rated the stock with a Buy rating and five have issued  a Hold rating to the stock. Based on data from MarketBeat.com, the company  has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $167.40.</p><ul><li>Investing in Sustainable Solutions: 2 Top Water Tech Stocks</li></ul><p><b>Get Our Latest Analysis on XYL</b></p><h2>Insider Buying and Selling</h2><p>In related news, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares of the company's stock, valued at approximately $4,770,000. This trade represents a 25.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, Director Victoria D. Harker sold 1,700 shares of the business's stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director directly owned 16,875 shares of the company's stock, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own  0.27% of the company's stock. </p><h2>Xylem Trading Down 0.5%</h2><p>Shares of Xylem stock opened at $137.59 on Wednesday. The firm has a 50-day simple moving average of $144.46 and a two-hundred day simple moving average of $139.31. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $154.27. The company has a market cap of $33.50 billion, a P/E ratio of 35.37, a price-to-earnings-growth ratio of 2.14 and a beta of 1.18. </p><p>Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion during the quarter, compared to analyst estimates of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.Xylem's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS.  As a group, equities analysts predict that  Xylem Inc. will post 4.65 earnings per share for the current fiscal year. </p><h2>Xylem Announces Dividend</h2><p>The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Tuesday, November 25th. Xylem's dividend payout ratio  is presently 41.13%. </p><h2>About Xylem</h2> (Free Report)<p>Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement &amp; Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Xylem</li><li>P/E Ratio Calculation: How to Assess Stocks</li><li>25 Years Later, Cisco Finally Recovers From the Dot-Com Crash</li><li>How to Use Stock Screeners to Find Stocks</li><li>AI Chips Can’t Exist Without These 2 Underrated Tech Giants</li><li>What Does a Gap Up Mean in Stocks? How to Play the Gap</li><li>Why Taiwan Semiconductor's 6.5% Dip Could Be a Smart Buy</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVhZTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVhZTA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Xylem Right Now?</h2><p>Before you consider Xylem, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.</p><p>While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Thurston Springer Miller Herd & Titak Inc. reduced its stake in Xylem Inc. by 91.7% in Q3, selling 18,715 shares. Xylem's stock opened at $137.59, with a market cap of $33.50 billion. Analysts have mixed ratings, with a consensus price target of $167.40. Insiders sold shares recently, affecting stock positions. Xylem's stock has a 52-week range of $100.47 to $154.27.</p>

Thurston Springer Miller Herd & Titak Inc. Sells 18,715 Shares of Xylem Inc. $XYL